| RE48286 | Steroids as agonists for FXR | Jun 21, 19 | Oct 27, 20 | Intercept Pharmaceuticals Inc. |
| RE46955 | Sulfated oligosaccharide derivatives | Sep 09, 16 | Jul 17, 18 | Progen PG500 Series Pty Ltd |
| 9993563 | Compounds and methods for trans-membrane delivery of molecules | Jul 28, 16 | Jun 12, 18 | Aposense Ltd. |
| 9968554 | Modified drugs for use in liposomal nanoparticles | Jun 12, 14 | May 15, 18 | The University of British Columbia |
| 9938315 | Chemical compounds and use thereof for improving muscular quality | May 20, 15 | Apr 10, 18 | INSTITUT BIOPHYTIS SAS; UNIVERSITÉ PARIS 6 PIERRE ET MARIE CURIE; |
| 9937259 | Abiraterone derivatives and non-covalent complexes with albumin | Jun 26, 15 | Apr 10, 18 | Zhuhai Beihai Biotech Co., Ltd. |
| 9938316 | Selective inhibitors of α2 isoform of Na,K-ATPase and use thereof for reduction of intra-ocular pressure and as cardiotonic agents | Aug 27, 14 | Apr 10, 18 | Yeda Research and Development Co. Ltd. |
| 9931419 | Methods and compositions for liposomal formulation of antigens and uses thereof | Jun 13, 16 | Apr 03, 18 | Molecular Express, Inc.; The Regents of the University of California; |
| 9920089 | Process for producing a solid form of abiraterone acetate | Apr 11, 14 | Mar 20, 18 | ZACH SYSTEM |
| 9884067 | Androgen receptor down-regulating agents and uses thereof | Mar 14, 14 | Feb 06, 18 | THOMAS JEFFERSON UNIVERSITY, UNIVERSITY OF MARYLAND, BALTIMORE, |
| 9868757 | 5-β, 14-β-androstane derivatives useful for the treatment of proteinuria, glomerulosclerosis and renal failure | Nov 03, 15 | Jan 16, 18 | CVIE THERAPEUTICS LIMITED |
| 9850272 | Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-hydroxy-steroid dehydrogenase, type 1 | Jun 25, 14 | Dec 26, 17 | FORENDO PHARMA LTD |
| 9850273 | Combination of estrogens plus antiprogestins with significant partial agonistic effect as an effective treatment of menopausal symptoms and for prevention of the occurrence of breast cancer | Dec 03, 15 | Dec 26, 17 | EVESTRA, INC. |
| 9821068 | Methods to induce targeted protein degradation through bifunctional molecules | May 06, 16 | Nov 21, 17 | DANA-FARBER CANCER INSTITUTE, INC. |
| 9814735 | Certain chemical entities, compositions, and methods | Jun 20, 16 | Nov 14, 17 | SUZHOU NEUPHARMA CO., LTD. |
| 9808472 | Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies | Aug 12, 14 | Nov 07, 17 | TOKAI PHARMACEUTICALS, INC., UNIVERSITY OF MARYLAND, BALTIMORE, UNIVERSITY OF WASHINGTON, |
| 9802978 | Progesterone phosphate analogs and uses related thereto | Aug 11, 14 | Oct 31, 17 | EMORY UNIVERSITY |
| 9790253 | OSW-1 analogs and conjugates, and uses thereof | May 18, 12 | Oct 17, 17 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 9790537 | Quinone-masked probes as labeling reagents for cell uptake measurements | Jan 29, 15 | Oct 17, 17 | PROMEGA CORPORATION |
| 9770512 | Methods to induce targeted protein degradation through bifunctional molecules | May 06, 16 | Sep 26, 17 | DANA-FARBER CANCER INSTITUTE, INC. |